Episode Details

Investors changed their minds about a former safe bet, refusing to buy the software sector’s stocks or lend its firms cash, while the US government’s new drug platform could mean cheaper medicine for you… and discounted pharma stocks, too.

Today’s stories:

• Investors Lost Faith In Software Firms, Wanting Higher Returns For Their Debt
• The White House (Ozem-)Picked Drugmakers Apart

Try Finimize Pro